ArticleFrontiers in oncology2025

Combining immune checkpoint inhibitors with thoracic radiotherapy enhances outcomes in advanced non-small-cell lung cancer: a real-world study.

Yao Zou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.